Bevacizumab combined with platinum–taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022…

Overview of attention for article published in International Journal of Clinical Oncology, July 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#47 of 905)
Good Attention Score compared to outputs of the same age (77th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

twitter: 2 X users

q&a: 3 Q&A threads

Citations

dimensions_citation: 48 Dimensions

Readers on

mendeley: 32 Mendeley

Summary X Q&A Dimensions citations

So far, Altmetric has seen 3 Q&A posts from 3 users.

Meaning of "platinum sensitivity and primary PFI being repowered as prognostic factors"

Posted by CopperKettle, at medicalsciences.stackexchange.com, 25 Jan 2019

Quote from a clinical trial report: Recurrence eventually affects 70–80% of patients with advanced epithelial ovar-ian…

Meaning of "Disease progression was not judged only from changes in the serum CA-125 level"

Posted by CowperKettle, at ell.stackexchange.com, 24 Jan 2019

Quote from a clinical trial report: The tumor response and disease progression were evaluated by computed tomography (CT…

Isn't "epithelial carcinoma" a tautological term? Are there non-epithelial carcinomas?

Posted by CopperKettle, at medicalsciences.stackexchange.com, 23 Jan 2019

From "Bevacizumab combined with platinum–taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective…

This page shows the most recent Q&A posts that mention this research output.

Click here to find out how to access more activity.